Modern Pediatrics. Ukraine. (2022). 4(124): 28-33. doi 10.15574/SP.2022.124.28
Marushko T.¹, Kurilina T. ¹, Taranenko T.¹, Marushko Yu.^2
1Shupyk National Healthcare University of Ukraine, Kyiv
²Bogomolets National Medical University, Kyiv, Ukraine

For citation: Marushko T, Kurilina T, Taranenko T, Marushko Yu. (2022). Features of the course of and diagnostics of juvenile localized scleroderma: analysis of clinical cases. Modern Pediatrics. Ukraine. 4(124): 28-33. doi 10.15574/SP.2022.124.28.
Article received: Jan 17, 2022. Accepted for publication: Apr 20, 2022.

Juvenile localized scleroderma is characterized by foci of atrophic skin and lying beneath tissues, but damage of deep soft tissues, bones and joints can be observed, which, in addition to cosmetic changes, can lead to functional disorders and pain. A comparison of literature data and personal observations about the features of the onset, the development of clinical symptoms, the course, results of laboratory and instrumental examinations in children with localized scleroderma was carried out.
Purpose – analyze your own data on the diagnosis and course of the pathological process in patients with localized form of juvenile scleroderma and based on the latest data from literary sources, we compare the own data with those from modern literature in the diagnosis of this rare disease.
Materials and methods. We observed 48 patients with juvenile scleroderma for the period 2010-2020. The ultrasound examination of blood vessels, ultrasound examination of the abdominal cavity organs, heart and joints, X-ray examination of the lungs and joints, electrocardiographic examination, MRI examination and the indices of autoimmune activity were determined.
Results. The features of the course and diagnosis of juvenile localized scleroderma have been analyzed, namely, local skin lesions in the form of multiple foci with later development of sclerosis and atrophy are observed, so as Raynaud’s syndrome, articular syndrome in the form of arthralgias. When conducting laboratory studies, indicators of general inflammatory activity in localized scleroderma are informative. Ultrasound examination of the skin and muscles versus traditional traumatic biopsy is an informative method for diagnosing changes in the dermis, subcutaneous tissue, soft tissues and blood vessels, which is a sign of active scleroderma.
Conclusions. Juvenile localized scleroderma has definite features of the clinical course, it is important to bear in mind when establishing the diagnosis: local skin lesion in the form of multiple foci with later development of sclerosis and atrophy, Raynaud’s syndrome, articular syndrome in the form of arthralgias, uninformative laboratory data, visceral damages are frequently manifested by functional disorders, unevenness pathological process in vessels with changes primarily in the intima-media complex, informative ultrasound examination of the skin and muscles.
The research was carried out in accordance with the principles of the Helsinki declaration. The study protocol was approved by the Local ethics committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
Key words: juvenile localized scleroderma, clinical manifestations, diagnosis.
REFERENCES

1. Adrovic А, Sahin S, Barut K et al. (2018). Juvenile Scleroderma-What has Changed in the Meantime? Current Rheumatology Reviews. 14: 219-225. https://doi.org/10.2174/1573397114666180423105056; PMid:29692255

2. Berezhnoy VV, Taranenko TV. (2017). Juvenile systemic scleroderma: problems of diagnosis and treatment (lecture). Sovremennaya pediatriya 7(87): 21-27. https://doi.org/10.15574/SP.2017.87.21

3. Constantin T, Foeldvar I, Pain CE et al. (2018). Development of minimum standards of care for juvenile localized scleroderma. Eur J Pediatr. 177: 961-977. https://doi.org/10.1007/s00431-018-3144-8; PMid:29728839

4. Idzior M, Sotniczuk M, Michalski E, Gietka P, Sudoł-Szopińska I. (2021). Ultrasonography, MRI and classic radiography of skin and MSK involvement in juvenile scleroderma. J Ultrason. 20 (83): 311-317. https://doi.org/10.15557/JoU.2020.0054; PMid:33500800 PMCid:PMC7830062

5. Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P. (2016). German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges. 14 (2): 199-216. https://doi.org/10.1111/ddg.12724; PMid:26819124

6. Li SC. (2018). Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin North Am. 65: 757-781. https://doi.org/10.1016/j.pcl.2018.04.002; PMid:30031497

7. Lis-Święty A, Janicka I, Skrzypek-Salamon A, Brzezińska-Wcisło L. (2017). A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients. J Eur Acad Dermatol Venereol. 31: 30-37. https://doi.org/10.1111/jdv.13790; PMid:27401109

8. Lis-Święty A, Skrzypek-Salamon A, Ranosz-Janicka I, Brzezińska-Wcisło L. (2017). Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences. J Eur Acad Dermatol Venereol. 31: 1595-1603. https://doi.org/10.1111/jdv.14197; PMid:28271552

9. Maloney E, Menashe SJ, Iyer RS et al. (2018). The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review. Pediatr Radiol. 48 (11): 642-1654. https://doi.org/10.1007/s00247-018-4177-x; PMid:29971479

10. Mirizio E, Liu C, Yan Q. (2021). Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin. Front Pediatr. 7 (9): 669116. https://doi.org/10.3389/fped.2021.669116; PMid:34164359 PMCid:PMC8215272

11. Raupov RK, Imelbaev AI, Kostik MM. (2020). Yuvenilnaya lokalizovannaya sklerodermiya s pozitsii detskogo revmatologa. Voprosyi diagnostiki. Voprosyi sovremennoy pediatrii. Nauchno-prakticheskiy zhurnal. 19 (2): 150-161. https://doi.org/10.15690/vsp.v19i2.2109

12. Teske NM, Jacobe HT. (2020). Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change. Br J Dermatol. 182 (2): 398-404. https://doi.org/10.1111/bjd.18097; PMid:31049928

13. Torok KS. (2012). Pediatric scleroderma: systemic or localized forms. Pediatr Clin North Am. 59: 381-405. https://doi.org/10.1016/j.pcl.2012.03.011; PMid:22560576 PMCid:PMC3459339

14. Trihan J, Perez-Martin A, Guillaumat J, Lanéelle D. (2021). Normative and pathological values of hemodynamic and Doppler ultrasound arterial findings in children. 5 (14): 24. URL: https://econtent.hogrefe.com/doi/pdf/10.1024/0301-1526/a000860.

15. Wortsman X. (2019). Why, how, and when to use color Doppler ultrasound for improving precision in the diagnosis, assessment of severity and activity in morphea. Journal of Scleroderma and Related Disorders. 4 (1): 28-34. https://doi.org/10.1177/2397198318799244; PMid:35382147 PMCid:PMC8922582

16. Zulian F, Culpo R, Sperotto F et al. (2019). Consensus-based recommendations for the management of juvenile localised scleroderma Ann Rheum Dis. 78 (8): 1019-1024. https://doi.org/10.1136/annrheumdis-2018-214697; PMid:30826775 PMCid:PMC6691928

17. Zulian F. (2017). Scleroderma in children. Best Pract Res Clin Rheumatol. 31 (4): 576-595. https://doi.org/10.1016/j.berh.2018.02.004; PMid:29773274